Editorial
The new basal insulin analog glargine U-300 enables flexible injection schedule
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S1
(November 2018)
Molecular imaging in large vessel vasculitis has come to stay
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S2
(November 2018)
Local modalities for inoperable hepatocellular carcinoma: radiofrequency ablation versus stereotactic body radiotherapy
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S3
(November 2018)
Calcium and/or vitamin D supplementation: could they affect your risks of colorectal cancer development or progression?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S4
(November 2018)
Search for a reliable biomarker of acute kidney injury: to the heart of the problem
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S5
(November 2018)
Tumor inactivation of E-cadherin: a new tool for breast cancer treatment?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S6
(November 2018)
HLA-B*58:01 is not the only risk factor associated with allopurinol-induced severe cutaneous adverse drug reactions
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S7
(November 2018)
TBX20 and the PROK2-PROKR1 pathway—new kid on the block in angiogenesis research
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S8
(November 2018)
Is B-type natriuretic peptide (BNP) similarly associated with mortality in patients with and without heart failure?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S9
(November 2018)
Durability of mitral valve repair for degenerative mitral regurgitation: is it gold all that glitters?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S10
(November 2018)
The benefits of youth sports participation should outweigh the risks
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S11
(November 2018)
Ifi204/p204, a new piece in the sepsis puzzle
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S12
(November 2018)
Validating innovations to improve recovery after heart surgery
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S13
(November 2018)
Genetics in systemic lupus erythematosus: entering the borough of cardiovascular risk
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S14
(November 2018)
Self-condensation culture for vascularized organoid
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S15
(November 2018)
Anticoagulation after mechanical aortic valve implantation: is it time to act after PROACT?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S16
(November 2018)
Cardiac troponin I—more than a biomarker for myocardial ischemia?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S17
(November 2018)
The status of medical expulsive therapy in the age of evidence-based medicine
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S18
(November 2018)
Osteochondral lesions of the talus: are we ready for metal?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S19
(November 2018)
Extracorporeal membrane oxygenation in acute respiratory distress syndrome: why is the EOLIA trial important?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S20
(November 2018)
Fusion heals the broken-hearted
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S21
(November 2018)
Evaluation of kinematic changes of intervertebral discs and the space available for the cord
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S22
(November 2018)
Immunoscore—has it scored for colon cancer precision medicine?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S23
(November 2018)
High-density lipoprotein lifts the “dark web” cast by neutrophils
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S24
(November 2018)
The hemodynamic effects of norepinephrine: far more than an increase in blood pressure!
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S25
(November 2018)
Screening of three-dimensional spheroids of ovarian cancer: identification of novel therapeutics targeting stemness and chemoresistance
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S26
(November 2018)
Surrogate study endpoints in the era of cancer immunotherapy
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S27
(November 2018)
LXRs are finally being adequately targeted in atherosclerosis
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S28
(November 2018)
EBOV-RNA test with RT-PCR in ocular fluids of Ebola survivors can help to safely perform cataract surgery
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S29
(November 2018)
Reforming disease classification system—are we there yet?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S30
(November 2018)
Treatment of induction in resectable NSCLC with chemotherapy, followed by surgery and erlotinib
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S31
(November 2018)
The answer is cilia, whatever the question may be!
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S32
(November 2018)
Standardising measures in pediatric rheumatology: the experience of the international consensus dataset for juvenile dermatomyositis
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S33
(November 2018)
Treating atherosclerosis: targeting risk factors should not be the only option
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S34
(November 2018)
Silent myocardial infarction and risk of heart failure
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S35
(November 2018)
We should not avoid diclofenac in the treatment of spondyloarthritis
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S36
(November 2018)
Endoscopic saphenous vein harvesting and surgical site infections after coronary artery bypass surgery
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S37
(November 2018)
Host-pathogen interactions in typhoid fever: the model is the message
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S38
(November 2018)
Ebola virus and persistent chronic infection: when does replication cease?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S39
(November 2018)
Pacific Rim redux: lorlatinib, the ultimate Jaeger?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S40
(November 2018)
Re-biopsy in lupus nephritis
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S41
(November 2018)
Neuropathic pain models and outcome measures: a dual translational challenge
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S42
(November 2018)
Simulation modeling for clinical trials evaluating radiotherapy omission in low-risk early breast cancer
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S43
(November 2018)
Discovering the genetic contribution to cardiovascular diseases in patients affected by autoimmune diseases
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S44
(November 2018)
The fecal microbiome directly drives immune activation in HIV infection
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S45
(November 2018)
Risk of peripheral artery disease in human immunodeficiency virus infected individuals
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S46
(November 2018)
The different path of T790M-positive EGFR-mutant lung cancer
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S47
(November 2018)
Non-invasive assessment of tumor PD-L1 status with circulating tumor cells
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S48
(November 2018)
Targeting selected extracellular matrix components to attenuate cardiac fibrosis
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S49
(November 2018)
Cardiovascular risk prediction in older adults with the use of biomarkers
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S50
(November 2018)
Radiologic features of small pulmonary nodules detected in initially negative screening CT examinations: a step towards personalized screening strategies?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S51
(November 2018)
Progressive nature of myocardial fibrosis in pediatric hypertrophic cardiomyopathy: from mutation carrier to myocardial fibrosis
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S52
(November 2018)
Epithelial plasticity is crucial for pancreatic cancer metastatic organotropism
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S53
(November 2018)
Issues in implementing lung cancer screening in United States and Europe
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S54
(November 2018)
Cholesterol homeostasis, macrophage malfunction and age-related macular degeneration
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S55
(November 2018)
New highlight in breast cancer development: the key role of hepcidin and iron metabolism
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S56
(November 2018)
MK-2206 window of opportunity study in breast cancer
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S57
(November 2018)
Cerebrovascular contribution to dementia development after traumatic brain injury: promises and problems
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S58
(November 2018)
Office-based spirometry to stratify the risk of postoperative complications
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S59
(November 2018)
Dasatinib in breast cancer: Src-ing for response in all the wrong kinases
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S60
(November 2018)
Cardioprotective effects of autophagy induction in sepsis
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S61
(November 2018)
Targeting properdin in the treatment of atypical haemolytic uraemic syndrome: better than eculizumab?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S62
(November 2018)
Microbial marauders: pancreatic microbiota and its impact on carcinogenesis
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S63
(November 2018)
Prediction of therapeutic effects of human cardiomyocytes in myocardial infarction using non-human primates model
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S64
(November 2018)
Concurrent chemoradiotherapy for stage III non-small cell lung cancer: correct clinical management as the basis to move beyond
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S65
(November 2018)
The risk factors for brain metastases in patients with non-small cell lung cancer
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S66
(November 2018)
Inferior vena cava variation predicts fluid responsiveness during dysrhythmias: a rational rearrangement of chairs on The Titanic
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S67
(November 2018)
Effect of sodium-glucose cotransporter type 2 inhibitors on liver fat in patients with type 2 diabetes: hepatic beyond cardiovascular and renal protection?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S68
(November 2018)
Laparoscopic Roux-en-Y gastric bypass or vertical sleeve gastrectomy: a weighty decision
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S69
(November 2018)
Understanding the link between traumatic brain injury and Alzheimer’s disease
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S70
(November 2018)
Novel mediators of breast cancer bone metastasis—insights from studies of gene-regulation and the global proteome
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S71
(November 2018)
Patient friendly intensification of basal insulin
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S72
(November 2018)
Out of darkness comes light—is there a role for light masks in treatment of diabetic macular oedema?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S73
(November 2018)
Cardiovascular disease in the youngest: is it time for precision prevention?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S74
(November 2018)
A pathogenic hierarchy for synovial fibroblasts in rheumatoid arthritis
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S75
(November 2018)
Health-related quality of life after curative-intent treatment of nonsmall cell lung cancer: can exercise lessen the burden?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S76
(November 2018)
Look around your target: a new approach to early diagnosis of lung cancer
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S77
(November 2018)
Sphingolipid metabolism products: potential new players in the pathogenesis of bortezomib-induced neuropathic pain
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S78
(November 2018)
Pharmacotherapy for gestational diabetes mellitus: still insulin, or what about sulfonylureas?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S79
(November 2018)
Simulation modeling approaches to answer clinically relevant questions in breast cancer low-risk populations
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S80
(November 2018)
Biomarker combination is necessary for the assessment of Gaucher disease?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S81
(November 2018)
Cardiovascular disease in patients with rheumatoid arthritis: impact of classic and disease-specific risk factors
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S82
(November 2018)
Mid-term results of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy compared—results of the SLEEVEPASS and SM-BOSS trials
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S83
(November 2018)
Post-immunotherapy new onset diabetes (PINOD)—underrecognized etiology, unexplored presentation
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S84
(November 2018)
Testosterone replacement in androgen insensitivity: is there an advantage?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S85
(November 2018)
Minimally invasive surgery for early stage lung cancers: satisfactory, but we can do better
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S86
(November 2018)
TAILORing targeted therapies to the right patient at the right time: how close are we?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S87
(November 2018)
Is there a relation between preserved renal function and oncological outcomes in patients undergoing partial nephrectomy for renal cell carcinoma?
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S88
(November 2018)
Liquid biopsy in tumors: opportunities and challenges
Annals of Translational Medicine
2018;
6
(Suppl 1)
:S89
(November 2018)
Disclosure:
The supplement was published without any sponsorship or funding.